Armer JM, Hulett JM, Bernas M, Ostby P, Stewart BR, Cormier JN, et al.
Current breast cancer reports. Date of publication 2013 Jun 1;volume 5(2):134-144.
1. Curr Breast Cancer Rep. 2013 Jun;5(2):134-144.
Best Practice Guidelines in Assessment, Risk Reduction, Management, and
Surveillance for Post-Breast Cancer Lymphedema.
Armer JM(1), Hulett JM(2), Bernas M(3), Ostby P(4), Stewart BR(5), Cormier JN(6).
Author information:
(1)Sinclair School of Nursing Director, Nursing Research, Ellis Fischel Cancer
Center Director, American Lymphedema Framework Project DC 116.05 Suite 415 EFCC
University of Missouri-Columbia Columbia, MO 62011.
(2)Sinclair School of Nursing University of Missouri-Columbia
Jmh5f3@mail.missouri.edu.
(3)Department of Surgery University of Arizona michaelb@u.arizona.edu.
(4)Sinclair School of Nursing University of Missouri-Columbia
Plo7c9@mail.missouri.edu.
(5)College of Education and Sinclair School of Nursing University of
Missouri-Columbia stewartb@missouri.edu.
(6)Departments of Surgical Oncology and Biostatistics The University of Texas MD
Anderson Cancer Center Houston, TX jcormier@mdanderson.org.
Breast cancer-related lymphedema (LE) is a progressive, chronic disease that
affects millions of cancer survivors and primarily results from surgical
lymphatic vessel/node removal and radiation therapy. Patient education and
support for importance of early detection is essential in helping health care
providers detect lymphedema early, when there is the best chance to prevent
progression. Improved imaging and surgical techniques have decreased the
incidence of LE; however, effective risk-reduction and treatment have
historically lacked the level of evidence necessary to standardize effective
treatment. The purpose of this article is to report an extensive review of
literature, including highlighted multidisciplinary studies within the past three
years, in order to update best practice guidelines in assessment, risk reduction,
management, and surveillance for post-breast cancer lymphedema.
DOI: 10.1007/s12609-013-0105-0
PMCID: PMC4523280
PMID: 26246870
